Clinical Trial Update: Phase 1a/b Study on Safety of IMX101 in H. Pylori-negative and H. Pylori-infected Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1a/b safety study to assess IMX101 in Helicobacter pylori-infected and HP-naive healthy volunteers has completed and will report safety data from health…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• IMX101

Snippet

Sponsor: ImevaX | Conditions: Helicobacter Pylori Infected Subjects, Helicobacter Pylori Naive Subjects | Phase 1 | Status: COMPLETED